Project description:Background: The sensitivity of head and neck squamous cell carcinoma (HNSCC) to ionizing radiation, among others, is determined by the number of cells with high clonogenic potential and stem-like features. These cellular characteristics are dynamically regulated in response to treat-ment and may lead to an enrichment of radioresistant cells with a cancer stem cell (CSC) pheno-type. Epigenetic mechanisms, particularly DNA and histone methylation, are key regulators of gene-specific transcription and cellular plasticity. Therefore, we hypothesized that specific epi-genetic targeting may prevent irradiation-induced plasticity and may sensitize HNSCC cells to radiotherapy. Methods: We compared the DNA methylome and intracellular concentrations of tricarboxylic acid cycle metabolites in radioresistant FaDu and Cal33 cell lines with their parental controls, as well as aldehyde dehydrogenase (ALDH)-positive CSCs with negative controls. Moreover, we conducted a screen of a chemical library targeting enzymes in-volved in epigenetic regulation in combination with irradiation and analyzed the clonogenic potential, sphere formation, and DNA repair capacity to identify compounds with both radiosensi-tizing and CSC-targeting potential. Results: We identified the histone demethylase inhibitor GSK-J1, which targets UTX (KDM6A) and JMJD3 (KDM6B), leading to increased H3K27 tri-methylation, heterochromatin formation, and gene silencing. The clonogenic survival assay after siRNA-mediated knock-down of both genes radiosensitized Cal33 and SAS cell lines. Moreover, high KDM6A expression in tissue sections of patients with HNSCC was associated with improved locoregional control after primary (n = 137) and post-operative (n = 187) radio/chemotherapy. Conversely, high KDM6B expression was a prognostic factor for reduced overall survival. Conclusions: Within this study, we investigated cellular and molecular mechanisms underlying irradiation-induced cellular plasticity, a key inducer of radioresistance, with a focus on epigenetic alterations. We identified UTX (KDM6A) as a putative prognostic and therapeutic target for HNSCC patients treated with radiotherapy.

			Action	DRS
	F151104_01_QE2_jbwills_P_PF_120_13-Radioresistant-cells-5-Gy-1-GB4.raw	Raw
	F151104_02_QE2_jbwills_P_PF_120_13-Radioresistant-cells-5-Gy-1-GB4.raw	Raw
	F151104_03_QE2_jbwills_P_PF_120_1-231-cells-1-GB1.raw	Raw
	F151104_04_QE2_jbwills_P_PF_120_1-231-cells-1-GB1.raw	Raw
	F151104_05_QE2_jbwills_P_PF_120_21-231-cells-FC9403A-1-GB6.raw	Raw

Dataset Information

Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells

Dataset's files

Publications

Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets